Skip to content

Treating More Than One Tibial Arteries in Patients with Chronic Limb Threatening Ischaemia is Associated with Fewer Major Re-interventions.

Jul 2026 · European Journal of Vascular and Endovascular Surgery · 0 citations
Medicine

TL;DR

In patients with diffuse tibial arterial occlusive disease, treatment of multiple tibial arteries rather than just one at the time of index revascularisation was associated with fewer major re-interventions and should be considered.

Abstract

Objective

It is unclear whether treating multiple diseased tibial arteries at initial revascularisation improves outcomes with chronic limb threatening ischaemia (CLTI). Using data from the Best Endovascular versus Best Surgical Therapy in Patients with CLTI (BEST-CLI) trial this study aimed to compare single arterial intervention (SAI) with multiple arterial intervention (MAI) for infrapopliteal disease.

Methods

A retrospective, as treated analysis of the endovascular dataset from the BEST-CLI trial was undertaken to compare SAI with MAI. Only patients with multiple tibial vessel arterial occlusive disease with > 50% stenosis were included. Evaluated outcomes included major re-interventions (new bypass, interposition graft, thrombectomy, or thrombolysis), major adverse limb events (MALE)/death, and above ankle amputations. Risk adjusted analysis was performed.

Results

There were 324 patients included: 224 SAI and 100 MAI. On unadjusted analysis at 3 years, SAI had a higher rate of a major re-intervention (19.2% vs. 5.3%; p = .010) and MALE/death (56.4% vs. 43.6%; p = .030), while there was no difference for above ankle amputation (19.7% vs. 13.1%; p = .14), amputation/death (45.2% vs. 43%; p = .53), or all cause death (37.7% vs. 33.5%, p = .57). SAI and MAI were associated with similar rates of resolution of initial CLTI symptoms (75.9% vs. 86%; p = .60). On risk adjusted analysis, SAI was associated with a higher rate of major re-intervention (odds ratio [OR] 3.14, 95% confidence interval [CI] 1.2 - 8.2; p = .019) than MAI; however, there was no increase in any re-intervention (OR 0.95, 95% CI 0.6 - 1.49; p = .80), MALE/death (OR 1.27, 95% CI 0.86 - 1.89; p = .24), above ankle amputation (OR 1.53, 95% CI 0.74 - 3.19; p = .25), initial CLTI resolution (OR 1.16, 95% CI 0.85 - 1.59; p = .36), or death (OR 1.03, 95% CI 0.64 - 1.63; p = .90).

Conclusion

In patients with diffuse tibial arterial occlusive disease, treatment of multiple tibial arteries rather than just one at the time of index revascularisation was associated with fewer major re-interventions and should be considered.

View source

Similar papers

Open access Jan 2026

Midterm Outcomes of Endovascular‐First Revascularization for Multilevel Peripheral Arterial Disease With Chronic Limb‐Threatening Ischemia: A Retrospective Study From Vietnam

Background Peripheral arterial disease (PAD) with chronic limb‐threatening ischemia (CLTI) represents advanced systemic atherosclerosis and carries high risks of amputation and mortality. Multilevel arterial involvement is common and often requires revascularization of both inflow and outflow segments. However, midterm...

Lam Van Nut, Nghia Vu Trinh · 0 citations
Aug 2026

TPTh 5.03 Outcomes Following Common Femoral Endarterectomy Without Distal Revascularisation: A Five-Year Cohort

Peripheral arterial disease involving the common femoral artery can cause chronic limb-threatening ischaemia (CLTI) and intermittent claudication (IC). Common femoral endarterectomy (CFE) +/- iliac intervention (inflow restoration) can alleviate symptoms, although may be inadequate for advanced CLTI or significan...

S. Fredrick, C. MacLeod, J. Nagy · 0 citations
Sep 2026

Full Endovascular vs Hybrid Repair of Common Femoral Artery Associated with Ipsilateral Concomitant Arterial Lesions in Septuagenarians Patients.

In septuagenarian patients, full endovascular repair of the CFA and ipsilateral concomitant lesions was associated with mid-term outcomes similar to those of hybrid surgery, while reducing hospital length of stay and perioperative complications.

Maribel Hupelier, Julien Sfeir, Clément Rouvière et al. · 0 citations
Aug 2026

2-Year outcomes of endovascular therapy of popliteal artery restenosis.

Background: To assess the mid-term outcome of endovascular treatment for popliteal artery restenosis. Patients and methods: This retrospective study included patients with peripheral artery disease (Rutherford class (RC) 2-5) and popliteal artery restenosis treated between January 2007 and December 2017. Patients were...

T. Böhme, E. Noory, U. Beschorner et al. · 0 citations
Review Open access Sep 2026

RESULTS OF REPEAT OPEN REVASCULARIZATION PROCEDURES IN PATIENTS WITH OCCLUSIVE-STENOTIC LESIONS OF THE LOWER EXTREMITY ARTERIES

Introduction. Occlusive-stenotic lesions of the lower extremity arteries may progress to chronic limb-threatening ischemia, limb loss, and marked functional impairment. Reocclusion after primary revascularization requires an individualized choice of repeat treatment.Aim. To assess the clinical results of repeat open re...

Y. Hupalo, Yaroslav M. Annyshynets, O. V. Ossovskyi et al. · 0 citations
Sep 2026

Clinical Outcomes of Santreva™-ATK Endovascular Revascularization Catheter in Patients with Claudication and Critical Limb-Threatening Ischemia.

BACKGROUND Patients with femoropopliteal (FP) chronic total occlusions (CTOs) presenting with intermittent claudication (IC) and chronic limb threatening ischemia (CLTI) differ in disease severity and lesion complexity. We performed a subgroup analysis of the prospective, multicenter RESTOR-1 trial to evaluate the safe...

Shalini Sharma, Anand Gupta, Peter A. Soukas et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.